Zurich Insurance Group (ZURN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
17 Nov, 2026Executive summary
H1 2024 BOP reached a record USD 3.988bn, up 7% year over year; NIAS rose 21% to USD 3.026bn and BOPAT ROE reached a record 25.0%.
All segments contributed to growth, including record Life and Farmers BOP; progress continued toward exceeding 2023-2025 targets.
Completed acquisition of a 70% stake in Kotak Mahindra General Insurance and agreed to acquire AIG’s global personal travel insurance business.
Financial highlights
P&C insurance revenue rose 6% to USD 21.446bn; gross written premiums and policy fees increased 3% to USD 25.342bn.
P&C BOP was USD 2.224bn, up 3% in local currencies; combined ratio was 93.6%.
Life BOP reached a first-half record USD 1.048bn, up 12%; Farmers BOP rose 12% to USD 1.115bn.
Net investment result rose 32% to USD 3.385bn; net investment return was 2.3%, versus 1.8% in H1 2023.
Outlook and guidance
EPS CAGR for 2023-2025 is expected to exceed 10%; outlook remains unchanged, with progress toward exceeding all cycle targets.
P&C insurance revenue expected to grow mid-single digit year over year; FY-24 Life BOP expected at least in line with record FY-23.
Farmers Exchanges GWP expected to grow mid-single digit; policy count expected to return to growth in 2025 as portfolio exits complete.
Commercial P&C conditions remain favorable, with continued opportunities for profitable growth.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023